
A greater family history (FH) of prostate cancer (PrCa) is associated with a lower risk of PrCA-specific and all-cause mortality, according to a study published in European Urology.
The investigators of this study sought to determine how the number, degree, and age of a PrCa patient’s affected relatives are associated with overall survival (OS) and PrCa-specific survival (PCSS) in patients already diagnosed with PrCa.
In this analysis, the researchers assessed OS and PCSS in 16,340 men from the The UK Genetic Prostate Cancer Study, which is a longitudinal, multi-institutional, observational study collated data since 1992. The primary end point of interest was defined as all-cause mortality among PrCa patients. The risk of mortality correlated with FH was analyzed using hazard ratios from Cox proportional hazard regression models.